Clinical and molecular approaches to well differentiated and dedifferentiated liposarcoma
AM Crago, S Singer - Current opinion in oncology, 2011 - journals.lww.com
AM Crago, S Singer
Current opinion in oncology, 2011•journals.lww.comAlthough complete surgical resection is currently the most effective treatment for WDLS and
DDLS, the majority of patients with retroperitoneal liposarcoma will eventually have
recurrence and die of disease. It is hoped that a multimodality approach, which incorporates
targeted therapies and complete surgical resection, will significantly improve patient
outcomes.
DDLS, the majority of patients with retroperitoneal liposarcoma will eventually have
recurrence and die of disease. It is hoped that a multimodality approach, which incorporates
targeted therapies and complete surgical resection, will significantly improve patient
outcomes.
Summary
Although complete surgical resection is currently the most effective treatment for WDLS and DDLS, the majority of patients with retroperitoneal liposarcoma will eventually have recurrence and die of disease. It is hoped that a multimodality approach, which incorporates targeted therapies and complete surgical resection, will significantly improve patient outcomes.
Lippincott Williams & Wilkins